CARDINAL HEALTH — Clindamycin Importer Profile
Pharmaceutical Importer · #1 buyer for Clindamycin · $3.5M import value · 97 shipments · UNITED STATES · DGFT Verified
CARDINAL HEALTH is the #1 importer of Clindamycin from India with $3.5M in import value and 97 verified shipments. CARDINAL HEALTH holds a 5.2% market share in Clindamycin imports based in UNITED STATES. The company sources from 1 verified supplier across 60 formulations shipped to 1 country. Overall, CARDINAL HEALTH imports 5 pharmaceutical products worth $10.0M across 4 therapeutic categories.
CARDINAL HEALTH — Clindamycin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Clindamycin to CARDINAL HEALTH?
Verified from 97 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ENCUBE ETHICALS PRIVATE LIMITED | $3.5M | 97 | 100.0% |
CARDINAL HEALTH sources Clindamycin from 1 verified Indian supplier based on 97 customs records. The primary supplier is ENCUBE ETHICALS PRIVATE LIMITED accounting for 100.0% of imports.
How Does CARDINAL HEALTH Compare to Nearest Clindamycin Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CARDINAL HEALTH ★ | UNITED STATES | $4.7M | 94 | $50.0K |
| 7 | AIM RX 3PL, LLC | UNITED STATES | $3.3M | 73 | $45.1K |
| 8 | EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $3.1M | 84 | $36.4K |
CARDINAL HEALTH ranks #1 among 1,029 Clindamycin importers from India. Average shipment value of $50.0K compared to the market average of $30.8K. The closest competitors by value are AIM RX 3PL, LLC and EVERSANA LIFE SCIENCE SERVICES.
Where Does CARDINAL HEALTH Import Clindamycin To?
Destination countries from 97 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $3.5M | 97 | 100.0% |
CARDINAL HEALTH imports Clindamycin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $3.5M.
What Clindamycin Formulations Does CARDINAL HEALTH Import?
| Formulation | Value | Shipments |
|---|---|---|
| CLINDAMYCIN PHOSPHATE & BENZOYL PEROXIDE | $250.0K | 5 |
| CLINDAMYCIN PHOSPHATE & BENZOYL PEROXIDEGEL, 1.2%/5% (45 GM) B.NO.3BF21 TO 3BF25 MFG DATE DEC 2023 EXP DATE NOV 2025NOS | $150.0K | 3 |
| CLINDAMYCIN PHOSPHATE TOPICAL LOTION, 1%,60ML B.NO.3CW27, 3CW26 MFG DATE DEC 2023 EXP DATE NOV 2025NOS | $150.0K | 3 |
| CLINDAMYCIN PHOSPHATE & BENZOYL PEROXIDEGEL, 1.2%/5% (45 GM) B.NO.4BF01 TO 4BF05 MFG DATE JAN 2024 EXP DATE DEC 2025NOS | $150.0K | 3 |
| CLINDAMYCIN PHOSPHATE TOPICAL LOTION 1%60ML (BATCH NO. 4CW39 4CW364CW384CW414CW434CW374CW454CW404CW444CW42 MFNOS | $150.0K | 3 |
| CLINDAMYCIN PHOSPHATE & BENZOYL PEROXIDEGEL,1.2%/5% (45 GM) B.No.4BF08,4BF10,4BF09,4BF11,4BF06,4BF07 MFG Dt.APR 2024 EX | $150.0K | 3 |
| CLINDAMYCIN (PHOSPHATE) GEL 1% 60GM (CLI | $121.7K | 5 |
| CLINDAMYCIN PHOSPHATE TOPICAL LOTION 1%-60GM (BATCH NO.4CW01,4CW05,4CW02,4CW04,4CW03, MFG.DT.JAN 2024, EXP.DT.DEC 2025)NOS | $115.9K | 3 |
| CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP1% 60ML B.NO.4BH074BH064BH054BH044BH08 MFG DATE JAN 2024 EXP DATE DEC 202NOS | $113.7K | 3 |
| CLINDAMYCIN (PHOSPHATE) GEL 1% 30GM (CLI | $106.6K | 3 |
CARDINAL HEALTH imports 60 distinct Clindamycin formulations from India. The top formulation is CLINDAMYCIN PHOSPHATE & BENZOYL PEROXIDE with 5 shipments worth $250.0K.
Regulatory Requirements: Importing Clindamycin into United States
What CARDINAL HEALTH and other importers must comply with to import Clindamycin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Clindamycin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Clindamycin from India and How Much Does CARDINAL HEALTH Import?
India exported $31.6M worth of Clindamycin through 7,242 shipments from 527 suppliers to 144 countries, serving 1,029 buyers globally. CARDINAL HEALTH imports $3.5M of this total, accounting for 5.2% of India's Clindamycin exports with 97 shipments from UNITED STATES. This is verified from 97 customs shipment records covering 60 distinct formulations.
What Is the Average Order Value for CARDINAL HEALTH's Clindamycin Imports?
CARDINAL HEALTH's average Clindamycin order value is $35.8K per consignment, based on 97 shipments totaling $3.5M. CARDINAL HEALTH is based in UNITED STATES and ranks #1 among all Clindamycin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Clindamycin to CARDINAL HEALTH?
CARDINAL HEALTH sources Clindamycin from 1 verified Indian supplier: ENCUBE ETHICALS PRIVATE LIMITED ($3.5M, 100.0%). This is based on 97 customs records.
How Does CARDINAL HEALTH Compare to Other Clindamycin Importers?
CARDINAL HEALTH ranks #1 among 1,029 Clindamycin importers from India with a 5.2% market share. The top 3 importers are CARDINAL HEALTH ($4.7M), AIM RX 3PL, LLC ($3.3M), EVERSANA LIFE SCIENCE SERVICES ($3.1M). CARDINAL HEALTH processed 97 shipments from UNITED STATES.
What Other Antibiotics Products Does CARDINAL HEALTH Import?
CARDINAL HEALTH also imports these antibiotics products. Each links to the detailed product page.
About CARDINAL HEALTH
CARDINAL HEALTH imports 5 products worth $10.0M. Beyond Clindamycin, top products include Diclofenac, Tetracycline, Exemestane, Alprazolam. View the complete CARDINAL HEALTH profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clindamycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clindamycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CARDINAL HEALTH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CARDINAL HEALTH's capped import value divided by total capped export value for Clindamycin across all Indian exporters.
- 5.Verified Records: This page is backed by 97 individual customs records matching CARDINAL HEALTH importing Clindamycin, covering 60 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 144+ countries, 1,029+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clindamycin Import Data for CARDINAL HEALTH
Access order-level details, pricing data, supplier connections, and competitive analysis for CARDINAL HEALTH's Clindamycin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CARDINAL HEALTH
Full Company Profile →
5 products · $10.0M total trade · 4 categories
CARDINAL HEALTH × Clindamycin
Verified from customs records
Company Overview
Top Products by CARDINAL HEALTH
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CARDINAL HEALTH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clindamycin. For current order-level data, contact TransData Nexus.